Study of TUB-040 in Patients With Recurrent or Progressive Uterine Cancer After Chemotherapy and Immune Therapy

​ Conditions: Uterine Endometrial Cancer

Interventions: Drug: TUB-040 – Dose escalation; Drug: TUB-040 – RP2D

Sponsors: Tubulis GmbH

Not yet recruiting Conditions: Uterine Endometrial Cancer
Interventions: Drug: TUB-040 – Dose escalation; Drug: TUB-040 – RP2D
Sponsors: Tubulis GmbH
Not yet recruiting